Skip to main content
# Title Department Research Member Research Year
61 Lectin-Like OLR1 3′ UTR Rs1050286 Gene Polymorphism and Plasma Oxidized-LDL in Coronary Artery Disease and Their Relation to Cardiovascular Risk and Outcomes Department of Anesthesia, Intensive care and Pain management Dr. Mohamed Ahmed Mohamed Mostafa 2022
62 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Dr. Noha gaber sayed 2022
63 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
64 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Dr. Shimaa Hassan Shabaan Hassan 2022
65 Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients Department of Cancer Biology Dr. Neveen Abdelazeem Abdelraheem 2022
66 Fine‑needle aspiration cytology versus core needle lymph node biopsy in axillary staging of breast cancer Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
67 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
68 Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized … Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2022
69 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Ahmed Hassan Othman Hassan 2022
70 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2022